cdmo.directory
← Compare landing

AmbioPharm vs Richter BioLogics

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAmbioPharmRichter BioLogics
SummaryFDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale.Germany-based CDMO specializing in GMP-compliant microbial production of recombinant proteins, peptides, plasmid DNA, and bacterial vaccines with bioreactor capacity up to 1,500 litres and regulatory clearance from FDA, EMA, ANVISA, PMDA, and MFDS.
Services
  • API Synthesis & Manufacturing
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • CMC Analytical Development
  • Recombinant Protein Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
Modalities
  • Peptide
  • Vaccine
  • Biologics (Other)
  • Peptide
  • Vaccine
Development capabilities
  • Analytical method development
  • Formulation development
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Substance (DS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Microbial
Locations
  • North Augusta, North Augusta, South Carolina, United States
  • Headquarters / Development & Manufacturing, Germany, Germany
CertificationsData not yet provided.
  • FDA · Identifier: FDA inspection - zero findings
  • EMA · Identifier: EMA verified
  • ANVISA · Identifier: ANVISA verified
  • PMDA · Identifier: PMDA verified

Find similar companies

AmbioPharm alternatives · Richter BioLogics alternatives

Markdown mirror: /compare/ambiopharm/richterbiologics.md